Takeda begins PIII trial of alogliptin in China.
Date:
03-13-11
Source: ChemDaily
Source: ChemDaily
Takeda Pharmaceutical commenced a randomized, double-blind PIII studyof its DPP-4 (dipeptidyl peptidase-4) inhibitor alogliptin (brandname in Ja...
Related News
Photos
More>>
trade
- The Schaeffler Group and Henan University of Science and Technology (HUST) begin
- Hailin Bearing Company Donations For The Disaster Zhouqu
- President Hu stresses economic restructuring, agricultural production while
- CBIA Director-general Liu Enshi Visited Xiangyang Automobile Bearing Co.,Ltd
- NTN Signs an Alliance Memorandum in the Bearing Business with Luoyang LYC
market
- Wafangdian JinFeng Took Part In Shanghai Bearing and Equipment Exhibition
- Director of Bangladesh Ministry of Transport Visited Xiangyang Bearing Company
- Shanghai Rabbit Participated in the 12th China International Bearing & Equipment
- Chairman of China Machinery Industry Federation visited the Longxi Corporation
- Germany Customers Visited Xiangyang Automobile Bearing Co., Ltd
finance
- Three Products of CSC Received Authentication
- LDB Participated the 12th China International Bearing and Equipment Exhibition
- New Look of ZWZ in 2010 China International Bearing & Equipment Exhibition
- NTN Participated in the 12th China International Bearing & Equipment Exhibition
- New Look of Xinxiang Sunrise in 2010 China International Bearing & Equipment